2-methoxy-1,4-naphthoquinone and 1,2-naphthoquinone

2-methoxy-1,4-naphthoquinone has been researched along with 1,2-naphthoquinone in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cordingley, MG; Graham, PL; Reamer, RA; Singh, SB	1
Carroll, PJ; DuHadaway, JB; Jaller, D; Kumar, S; LaLonde, JM; Malachowski, WP; Metz, R; Muller, AJ; Prendergast, GC	1

Other Studies

2 other study(ies) available for 2-methoxy-1,4-naphthoquinone and 1,2-naphthoquinone

Article	Year
Discovery, total synthesis, HRV 3C-protease inhibitory activity, and structure-activity relationships of 2-methoxystypandrone and its analogues. Bioorganic & medicinal chemistry letters, 2001, Dec-17, Volume: 11, Issue:24 Topics: 3C Viral Proteases; Cysteine Endopeptidases; Naphthoquinones; Protease Inhibitors; Structure-Activity Relationship; Viral Proteins	2001
Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors. Journal of medicinal chemistry, 2008, Mar-27, Volume: 51, Issue:6 Topics: Animals; Antineoplastic Agents; Binding Sites; Cell Proliferation; Cell Survival; Computer Simulation; Crystallography, X-Ray; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Mice, Knockout; Mice, Nude; Models, Molecular; Molecular Structure; Naphthoquinones; Pyrones; Stereoisomerism; Structure-Activity Relationship; Vitamin K 3	2008

Article

Year

Discovery, total synthesis, HRV 3C-protease inhibitory activity, and structure-activity relationships of 2-methoxystypandrone and its analogues.

Bioorganic & medicinal chemistry letters, 2001, Dec-17, Volume: 11, Issue:24

Topics: 3C Viral Proteases; Cysteine Endopeptidases; Naphthoquinones; Protease Inhibitors; Structure-Activity Relationship; Viral Proteins

2001

Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors.

Journal of medicinal chemistry, 2008, Mar-27, Volume: 51, Issue:6

Topics: Animals; Antineoplastic Agents; Binding Sites; Cell Proliferation; Cell Survival; Computer Simulation; Crystallography, X-Ray; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Mice, Knockout; Mice, Nude; Models, Molecular; Molecular Structure; Naphthoquinones; Pyrones; Stereoisomerism; Structure-Activity Relationship; Vitamin K 3

2008